# Analysis of Cardiovascular Risk Factors in Patients with Psoriasis: A Cross-Sectional Study

**Authors:** Barbara S. Kahlow, Ana Paula Beckhauser, Thelma L. Skare, Renato Nisihara

PMC · DOI: 10.31138/mjr.300125.pac · 2025-07-17

## TL;DR

This study found that psoriasis patients have higher atherosclerotic risk factors and thicker carotid walls than controls, but arthritis status did not further increase the risk.

## Contribution

The study provides new evidence on cardiovascular risk in psoriasis patients, showing no added risk from arthritis.

## Key findings

- Psoriasis patients had higher rates of diabetes and hypertension compared to controls.
- Carotid intima-media thickness was significantly greater in psoriasis patients.
- No significant differences were found between psoriasis patients with and without arthritis.

## Abstract

This study aimed to evaluate and compare atherosclerotic risk factors and carotid intima-media thickness (cIMT) between psoriasis patients with and without arthritis.

Data on demographics, clinical characteristics, comorbidities, and treatments were collected in the medical charts. Laboratory assessments, including lipid profile and fasting glucose, were performed, along with cIMT measurements via ultrasound.

A total of 127 participants were analysed, including 49 controls and 78 psoriasis patients (47 with psoriatic arthritis and 31 without). Psoriasis patients exhibited a higher frequency of diabetes (OR=2.3; 95% CI=1.009–5.08) and hypertension (OR=6.8; 95% CI=1.7–30.8) compared to controls. Additionally, cIMT values were significantly elevated in psoriasis patients compared to controls (median 0.68 mm vs. 0.57 mm, p=0.001). However, no significant differences in traditional atherosclerotic risk factors or cIMT measurements were observed between psoriasis patients with and without arthritis (all p>0.05).

Psoriasis patients, regardless of arthritis status, exhibit increased atherosclerotic risk compared to controls. However, in this sample, it was not possible to prove that the presence of arthritis further exacerbates this risk.

## Linked entities

- **Diseases:** psoriasis (MONDO:0005083), diabetes (MONDO:0005015), psoriatic arthritis (MONDO:0011849)

## Full-text entities

- **Genes:** IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CIMT (Carotid intimal medial thickness) [NCBI Gene 404677], IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** PASI (MESH:D045169), Psoriasis (MESH:D011565), Atherosclerosis (MESH:D050197), atopic dermatitis (MESH:D003876), atherosclerotic plaques (MESH:D058226), DM (MESH:D003920), metabolic syndrome (MESH:D024821), chronic (MESH:D002908), swelling (MESH:D004487), cardiovascular disease (MESH:D002318), PsA (MESH:D015535), myocardial infarction (MESH:D009203), arthritis (MESH:D001168), pain (MESH:D010146), skin (MESH:D012871), ankylosing spondylitis (MESH:D013167), inflammation (MESH:D007249), weight gain (MESH:D015430), peripheral vascular disease (MESH:D016491), spondylarthritis (MESH:D025241), erythema (MESH:D004890), obesity (MESH:D009765), hypertension (MESH:D006973), desquamation (MESH:D017490), induration (MESH:D010411), sarcopenia (MESH:D055948), tenderness (MESH:D063806), renal failure (MESH:D051437), neoplasms (MESH:D009369), RA (MESH:D001172), autoimmune and autoinflammatory disorder (MESH:D056660), stiffness (MESH:C566112), lupus (MESH:D008180)
- **Chemicals:** Cholesterol (MESH:D002784), alcohol (MESH:D000438), triglycerides (MESH:D014280), lipid (MESH:D008055), glucose (MESH:D005947)
- **Species:** Rahnella sp. N (species) [taxon 291580], Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12835914/full.md

---
Source: https://tomesphere.com/paper/PMC12835914